Literature DB >> 12543645

In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes.

Marianne Stettler1, Renate Fink, Mirjam Walker, Bruno Gottstein, Timothy G Geary, Jean François Rossignol, Andrew Hemphill.   

Abstract

When humans serve as inadvertent intermediate hosts for Echinococcus multilocularis, disease (alveolar echinococcosis [AE]) may result from the expanding parasite metacestode in visceral organs, mostly in the liver. Benzimidazole carbamate derivatives such as mebendazole and albendazole are used for chemotherapeutic treatment of AE. However, these treatments are, in most cases, parasitistatic rather than parasiticidal. As treatment is discontinued, a recurrence of parasite growth has been observed in many AE patients with nonradical resections. The only curative treatment for AE is radical surgical resection of the parasite tissue and support by chemotherapy. As there is a need for new treatment options for AE, the in vitro efficacy of nitazoxanide (NTZ), a broad-spectrum drug used against intestinal parasites and bacteria, was investigated. We showed that in vitro treatment of E. multilocularis metacestodes with NTZ induced high levels of alkaline phosphatase activity in the medium. Concurrently, distinct morphological and ultrastructural alterations were detected. Most significantly, two distinct types of alterations were observed as soon as after 3 h of NTZ treatment. At first, the drug induced a peripheral output of membranous vesicles from the tegumental membrane into the laminated layer. Simultaneously, germinal layer-associated undifferentiated cells produced large vacuoles filled with lipid-like and often electron-dense membranous segments. Other alterations were observed at later time points, including vacuolization of the germinal layer, accumulation of lipid droplets, and lastly, loss of microtriches and separation of the laminated and germinal layers. The pattern of damage induced by NTZ was different from the alterations earlier observed in albendazole sulfoxide-treated vesicles. The nonviability of NTZ-treated metacestodes was confirmed through bioassay, i.e., inoculation of treated and untreated parasites into mice. These experiments demonstrate the in vitro parasiticidal effect of NTZ on E. multilocularis metacestodes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543645      PMCID: PMC151752          DOI: 10.1128/AAC.47.2.467-474.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes.

Authors:  K Ingold; P Bigler; W Thormann; T Cavaliero; B Gottstein; A Hemphill
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico.

Authors:  R Romero Cabello; L R Guerrero; M R Muñóz García; A Geyne Cruz
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Nov-Dec       Impact factor: 2.184

3.  Successful treatment of human fascioliasis with nitazoxanide.

Authors:  J F Rossignol; H Abaza; H Friedman
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Jan-Feb       Impact factor: 2.184

4.  In vitro and in vivo activities of nitazoxanide against Clostridium difficile.

Authors:  C S McVay; R D Rolfe
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Nitazoxanide: pharmacokinetics and metabolism in man.

Authors:  J Broekhuysen; A Stockis; R L Lins; J De Graeve; J F Rossignol
Journal:  Int J Clin Pharmacol Ther       Date:  2000-08       Impact factor: 1.366

Review 6.  Alveolar echinococcosis in humans: the current situation in Central Europe and the need for countermeasures.

Authors:  J Eckert; P Deplazes
Journal:  Parasitol Today       Date:  1999-08

Review 7.  Echinococcosis: an emerging or re-emerging zoonosis?

Authors:  J Eckert; F J Conraths; K Tackmann
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

8.  Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers.

Authors:  A Stockis; X Deroubaix; R Lins; B Jeanbaptiste; P Calderon; J F Rossignol
Journal:  Int J Clin Pharmacol Ther       Date:  1996-08       Impact factor: 1.366

9.  Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells.

Authors:  G Gargala; A Delaunay; X Li; P Brasseur; L Favennec; J J Ballet
Journal:  J Antimicrob Chemother       Date:  2000-07       Impact factor: 5.790

10.  A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico.

Authors:  J F Rossignol; H Hidalgo; M Feregrino; F Higuera; W H Gomez; J L Romero; J Padierna; A Geyne; M S Ayers
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Nov-Dec       Impact factor: 2.184

View more
  35 in total

1.  Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts.

Authors:  S Mahanty; A Paredes; M Marzal; E Gonzalez; S Rodriguez; P Dorny; C Guerra-Giraldez; H H Garcia; T Nash
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

2.  Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularis.

Authors:  Alexander Mathis; Peter Wild; Erik C Boettger; Christian M O Kapel; Peter Deplazes
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Ultrastructural changes in hydatid cyst walls obtained from human cases, exposed to different therapeutic approaches.

Authors:  Hoda Abdel Aziz Al Shinawy Shaheen; Saedia Abdel Hady Sayed El-Ahl; Amr Mahmoud Abdel Raouf; Marwa Ahmed El-Dardiry; Manal A Badawi; Amany Ahmed Abdel Aal
Journal:  Parasitol Res       Date:  2019-10-02       Impact factor: 2.289

4.  Isolation and characterization of a secretory component of Echinococcus multilocularis metacestodes potentially involved in modulating the host-parasite interface.

Authors:  Mirjam Walker; Adriana Baz; Sylvia Dematteis; Marianne Stettler; Bruno Gottstein; Johann Schaller; Andrew Hemphill
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps.

Authors:  Siddhartha Mahanty; Elise M Madrid; Theodore E Nash
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

6.  In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis.

Authors:  David Richter; Joachim Richter; Beate Grüner; Kathrin Kranz; Juliane Franz; Peter Kern
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

7.  In vitro and in vivo activities of dicationic diguanidino compounds against Echinococcus multilocularis metacestodes.

Authors:  Tatiana Küster; Nadja Kriegel; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

8.  Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Luis Lopera; Cesar Jayashi; Roxana Angelats; Eduardo A Barron; Berenice Ninaquispe; Lucia Villarreal; Hector H Garcia; Manuela R Verastegui; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

9.  Arsenic trioxide negatively affects Echinococcus granulosus.

Authors:  Bo Wang; Yufeng Jiang; Zhuo Wang; Fangfang Li; Guoqiang Xing; Xinyu Peng; Shijie Zhang; Hailong Lv
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

10.  In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives.

Authors:  Martin Spicher; Carole Roethlisberger; Catharina Lany; Britta Stadelmann; Jennifer Keiser; Luis M Ortega-Mora; Bruno Gottstein; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.